Centene Expects To Reaffirm FY24 Adjusted EPS Guidance Of Greater Than $6.80, Est $6.85
Portfolio Pulse from Benzinga Newsdesk
Centene expects to reaffirm its FY24 adjusted EPS guidance of greater than $6.80, with an estimated $6.85. The company also anticipates a consolidated health benefits ratio range of 87.3% to 87.9%. Key insights include higher than expected claims receipts in April for its Medicaid segment and continued strong performance in the Marketplace segment.
May 29, 2024 | 8:58 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Centene reaffirms its FY24 adjusted EPS guidance of greater than $6.80, with an estimated $6.85. The company also expects higher claims receipts in its Medicaid segment and strong performance in its Marketplace segment.
Reaffirming the EPS guidance and providing positive insights into Medicaid and Marketplace performance are likely to boost investor confidence and positively impact the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100